Featured
Last news
SideChannel Announces Anna Seacat Appointed to Board of Directors
WORCESTER, MA / ACCESS Newswire / December 9, 2025 / SideChannel, Inc. (OTCQB:SDCH) ("SideChannel"), a leading provider of cybersecurity services and technology from emerging to enterprise companies, today announced the appointment Anna Seacat to its Board of Directors underscoring SideChannel's dedication to leadership excellence and innovation in addressing cybersecurity challenges.
Nextech3D.ai to Acquire Krafty Labs, Expanding AI Event Solutions for Enterprise Clients
Krafty Labs Generated 2025 Year to date Revenue of $1.1 mill with a 72% gross marginAll-Cash Deal for $600,000Acquiring a Blue Chip customers list; Google, Meta, Oracle etcNextech3d.ai Doubles Customer Base to 1000+Nextech3d.ai is Accelerating its Growth As a One-Stop AI Event Tech Suite
e& Selects Amdocs to Power Its Generative AI Experiences
Leveraging Amdocs' amAIz - generative AI Platform and its agents, powered by NVIDIA AI Enterprise, e& UAE is integrating generative AI into its business processes, opening possibilities for new revenue opportunities, business efficiencies, and improved customer experiences
CXAI Announces Results from Landmark Enterprise Deployment as Global Workplace Disruption Creates an up to Trillion Dollar Agentic AI Opportunity For Employee Engagement
Enterprise adoption accelerates as CXAI strengthens its position at the center of the workplace experience and enterprise Agentic AI markets
IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial
POTOMAC, MARYLAND / ACCESS Newswire / December 9, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company leveraging Artificial Intelligence (AI) to develop innovative treatments for Alzheimer's disease, today announced it has reached a key enrollment milestone of 65% for its ongoing Phase 2 CALMA clinical trial evaluating IGC-AD1 for the treatment of agitation in Alzheimer's disease.
TNCDP, Inc Announces Full Alliance Group as First Public Company to Adopt Blueprint Series QDP(TM) Digital Preferred Framework
BRISTOL, TN / ACCESS Newswire / December 9, 2025 / TNCDP, Inc. (Trusted Network for Corporate Digital Preferred), the leading provider of compliant blockchain-based preferred equity frameworks, today announced that Full Alliance Group, Inc. (OTCID:FAGI) has become the first publicly traded company to adopt the Series QDP™ (Quantum Digital Preferred) framework for tokenizing its preferred stock. This milestone marks a transformative moment in the evolution of corporate capital structures and digital securities markets.
Autonomous Finance Needs a Control Layer; HUB Cyber Security Is Building It
TEL AVIV, IL / ACCESS Newswire / December 9, 2025 / A fundamental shift is taking place across global finance. Institutions are not simply modernizing their workflows or migrating legacy systems into the cloud. They are preparing for a future defined by autonomous engines that operate at speeds and levels of precision no human team can match. Trading models driven by machine reasoning, real-time settlement networks, automated underwriting, onboarding, and identity flows built on authentication are becoming the new operating standard. Software is no longer supporting decisions. It is making them.
Hememics' Graphene-Based ESAP(TM) Platform Validated by KanPro Research, Securing Commercial Trial Order
Deployment addresses the $1 billion antibody-reproducibility crisis by enabling rapid, objective validation of research reagents, reducing wasted time and cost in research and drug development.
Trump says to sign order blocking AI regulation by states
President Donald Trump said Monday he will attempt to strip states of the right to regulate the surging AI industry, arguing centralized rulemaking is vital to maintain US dominance.
AI tools help choose best embryos for IVF
Artificial intelligence tools can now help choose the most promising embryos for in vitro fertilisation (IVF), although experts have warned of some ethical concerns.
Optex Systems Holdings Announces Chad George as Chief Executive Officer
RICHARDSON, TX / ACCESS Newswire / December 8, 2025 / Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and global military and commercial applications, is pleased to announce the promotion of Chad George to President and Chief Executive Officer, effective December 20, 2025. Mr. George previously served as President and will now assume full executive leadership of the organization.
LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities
BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / In recent years, LIXTE (NASDAQ:LIXT) has been defined by LB-100, its first-in-class PP2A inhibitor with a mechanism that unlocks new therapeutic angles for resistant cancers. The company built its early identity around that science, and for good reason. LB-100 remains one of the few agents capable of disrupting a key cellular checkpoint cancer relies on for survival. Late 2025 added a new dimension to that storyline. With the acquisition of Liora Technologies, LIXTE signaled a transition from a pure biotech into a multi-layered oncology platform. The theme is not reinvention. It is expansion.
Ondas Announces Intent to Invest up to $11 Million in Drone Fight Group to Accelerate Access to Advanced Ukrainian Drone Technology
First strategic investment by Ondas Capital intended to strengthen U.S. and allied defense modernization priorities with combat-proven Ukrainian technologiesOndas Capital plans to support localization via U.S.-based, NDAA-compliant manufacturing and integrated customer support, training and sustainment
Regentis Biomaterials Commences Trading on NYSE: Set to Transform Cartilage Repair Market with Off-the-Shelf Regenerative Product
Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee cartilage repair, is a breakthrough effective and economical procedure to address a large unmet needGelrinC is approved for knee cartilage repair in the European Union and is currently at midpoint in a pivotal FDA trial for the same indication to address a U.S. market of more than 470,000 potential cases annuallyUpcoming expected catalysts include commercial launch in Europe and submission to FDA for approval in U.S.
The Global Infrastructure of Trust Is Being Rebuilt, and HUB Cyber Security Is Becoming One of Its Architects
TEL AVIS, IL / ACCESS Newswire / December 8, 2025 / For years, cybersecurity companies have trained the market to think in terms of software updates, dashboards, and breach containment. HUB Cyber Security (NASDAQ:HUBC) is operating on an entirely different level. It's not focused on the alerts. It's focused on the foundation, advancing a view of digital trust that begins where most cybersecurity firms end: at the hardware layer, where identity, authenticity, and verification must be absolute.
HUB Cyber Security Turns Regulatory Pressure Into Institutional Speed
TEL AVIV, IL / ACCESS Newswire / December 8, 2025 / Global institutions have lived with the same quiet limitation for decades. Regulation keeps tightening, data volumes keep expanding, and the systems responsible for proving compliance cannot keep up. Banks spend months fixing workflow gaps. Asset managers navigate fragmented reporting tools. Digital-asset platforms fight an endless battle to reassure regulators that their operations are clean. The issue has never been intent. It has always been infrastructure. Most compliance architectures were built for an earlier era of finance.
Resemble AI Raises $13M From Sony Innovation Fund, Okta Ventures and Others to Tackle AI-Generated Threats as Deepfake Cyberattacks Surge Against Global Enterprises
Company Launches Industry's Strongest Detection Model to Protect Digital Integrity and Unveils 2026 Deepfake Threat Predictions
QNX to Showcase Innovations for Software-Defined Vehicles and Mission-Critical Embedded Systems at CES 2026
WATERLOO, ONTARIO / ACCESS Newswire / December 8, 2025 / QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB), has announced it will showcase the latest advancements in its mission-critical embedded systems and automotive software product portfolio, including a new demo of its Foundational Vehicle Software Platform developed in collaboration with Vector, at CES 2026.
Snaplii Reminds Shoppers of Special Cashback Offers During Holiday Season
It's the last call for the smart shopping app's holiday promotions, which provide increasing cashback rewards at spending milestones and offer double cashback rewards on select brands through Monday, Dec. 15.
Ayrmid Presents New Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required by gene therapies for sickle cell disease within a single apheresis cycleKey HighlightsMotixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a single apheresis session.Motixafortide alone and in combination with natalizumab mobilized 2.7 and 2.8 fold greater HSCs, relative to plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSCs for people with sickle cell disease enabling accelerated access to gene therapiesData from study shows that motixafortide was safe and well toleratedFindings presented at ASH 2025
intive Announces Strategic Enterprise Partnership with Cursor to Advance AI-Native Transformation
REGENSBURG, DE / ACCESS Newswire / December 8, 2025 / intive announced today a strategic enterprise partnership with Cursor that accelerates the company's AI-Native Transformation Program. This milestone formalizes a relationship that has been evolving over several months, introducing dedicated engineering support and enterprise-grade enablement that strengthens AI-native engineering capabilities across teams and client engagements.
Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia Presented at ASH
New data presented at the 2025 ASH demonstrates 94% disease free and overall survival rateOmisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic AnemiaKey Highlights of Data Presented at ASH:95% of patients achieved rapid neutrophil recoveryMedian time to neutrophil recovery: 8 daysImmune recovery post-transplant was rapid94% disease-free and overall survivalNo cases of BMT-CTN severe acute graft-versus-host disease (GVHD), or chronic GVHD observedOmisirge approved by the FDA on December 5, 2025 for SAA
Unusual Machines and Dynamic Aerospace Systems Enter Supplier Agreement for U.S.-Made, NDAA-Compliant Drone Components
Partnership supports DAS's expanding commercial logistics operations in the Middle East and Europe
Greenlane Buys $8 Million worth of BERA, Maintains Approximately $32 Million Cash and Stablecoin Reserves for Berachain Treasury Strategy
BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (Nasdaq:GNLN), a Berachain-focused digital asset treasury company and global seller of premium cannabis accessories, and subsequent to the Company's press releases issued on October 24, 2025 and November 14, 2025 that disclosed Greenlane's Berachain cryptocurrency treasury strategy (the "Berachain Treasury Strategy"), is providing an update on its BERA token holdings, staking activity, and capital position related to its participation in the Berachain ecosystem.
Califf Surveying Becomes Leading Supplier of Leica Total Stations in Asia
Singapore-based surveying authority expands Leica product offerings, delivering unmatched accuracy and innovation to engineering, construction, and infrastructure sectors.
Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease
Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies90% (9 of 10) of patients were able to collect sufficient HSC to enable progress to gene therapy manufacturing86% (6 of 7) of patients had previously failed to collect sufficient cells with plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease for gene therapiesFindings presented at ASH 2025
Meta partners with news outlets to expand AI content
Meta announced Friday it will integrate content from major news organizations into its artificial intelligence assistant to provide Facebook, Instagram and WhatsApp users with real-time information.
Softbank's Son says super AI could make humans like fish, win Nobel Prize
Softbank CEO and AI investor Masayoshi Son said Friday that advanced artificial intelligence could surpass humans to the extent that "we become fish" and could even win the Nobel Prize in Literature.
Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
MONROE TOWNSHIP, N.J / ACCESS Newswire / December 5, 2025 / Ocean Power Technologies, Inc. ("OPT" or "the Company") (NYSE American:OPTT) today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.
The Compliance Wars Are Here, and HUB Cyber Security Just Declared It's Done Playing Small
TEL AVIV, IL / ACCESS Newswire / December 5, 2025 / HUB Cyber Security (NASDAQ:HUBC) spent years being treated like a niche player. Too technical for the digital asset crowd. Too advanced for legacy cybersecurity buyers. Too ahead of its time for analysts who couldn't model anything that didn't fit neatly into last decade's boxes.
Akanda Is Slowly Controlling the Map Behind Mexico's Telecom Boom
TORONTO, ON / ACCESS Newswire / December 5, 2025 / Akanda Corp. (NASDAQ:AKAN) is no longer behaving like an operator trying to find space inside Mexico's telecom upgrade. The company is acting like the landlord everyone else eventually has to call. Through its wholly owned subsidiary, First Towers & Fiber, Akanda controls the vertical real estate carriers depend on and the horizontal routes that move the data itself. When the infrastructure under a national network begins to consolidate, the companies holding the ground win first. That is the position Akanda has quietly engineered for itself.
FDA approves Omisirge(R) as First Approved Cell Therapy to Treat Severe Aplastic Anemia
Study demonstrated early and sustained hematopoietic recovery and transfusion independenceOmisirge is a new and novel transplant option for patients with SAAAdditional manufacturing capacity for Omisirge will be established in the U.S.Represents a supplementary FDA approval for Omisirge